Skip to main content

A

Stock
Health Care
Diagnostics & Research

Performance overview

A Price
Price Chart

Forward-looking statistics

Beta
0.72
Risk
25.64%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Company info

SectorHealth Care
IndustryDiagnostics & Research
Employees37K
Market cap$38.8B

Fundamentals

Enterprise value$35.7B
Revenue$6.6B
Revenue per employee
Profit margin17.59%
Debt to equity60.04

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)$4.05
Dividend per share$0.99
Revenue per share$23.18
Avg trading volume (30 day)$259M
Avg trading volume (10 day)$213M
Put-call ratio

Macro factor sensitivity

Growth+0.2
Credit+5.6
Liquidity-0.5
Inflation-3.1
Commodities-0.1
Interest Rates-1.4

Valuation

Dividend yield0.82%
PEG Ratio21.48
Price to sales5.20
P/E Ratio21.48
Enterprise Value to Revenue5.39
Price to book5.62

Upcoming events

Next earnings dayMay 29, 2025
Next dividend day
Ex. dividend dayJuly 1, 2025

News

Musk says he does not support a merger between Tesla and xAI but backs investment

Elon Musk on Monday said he does not support a merger between xAI and Tesla. On X, Musk suggested that Tesla plans to ask shareholders whether Tesla should invest in xAI, however.

CNBC (July 14, 2025)
Alibaba-backed Moonshot releases new Kimi AI model that beats ChatGPT, Claude in coding — and it costs less

Alibaba-backed startup Moonshot released late Friday night its Kimi K2 model as a low-cost, open source large language model, with a focus on coding capabilities. Moonshot claimed Kimi K2 surpassed Claude Opus 4 on two benchmarks, and had better overall performance than OpenAI's coding-focused GPT-4.1 model, according to several industry metrics.

CNBC (July 14, 2025)
Nvidia CEO downplays U.S. fears that China's military will use his firm's chips

"They don't need Nvidia's chips, certainly, or American tech stacks in order to build their military," Nvidia CEO Jensen Huang said in an interview with CNN aired Sunday. The comments came as Huang attempted to walk a tightrope between Beijing and the U.S. ahead of his second trip to China this year.

CNBC (July 14, 2025)
Elon Musk says Tesla shareholders will vote on investing in xAI

Elon Musk said Tesla will hold a shareholder vote on whether to invest in xAI. Musk said in March that xAI was valued at $80 billion.

Business Insider (July 14, 2025)
Bitcoin Tops $120,000 For The First Time

The price of bitcoin surpassed $120,000 for the first time late on Sunday, the latest milestone for the world's most valuable cryptocurrency, which has continued to rally over the past few weeks alongside other top tokens.

Forbes (July 14, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free